Scientific Advisory Committee

The Organizing Committee is proud to announce the Scientific Advisory Committee for BioProcessing Asia 2018 and 2020.

This specialist group will advise the Organizing Committee on new trends and recent advances in the field, Scientific Session topics, key presenters and other aspects of the Conference organisation.

 

Yuki Abe, Director of Bioprocess Economic Modeling & Design, Biopharm Services, Chesham, UK
Expertise: Whole bioprocess design and bioprocess economics (antibodies, gene therapy, vaccines), process simulation, supply chain, knowledge management, business development

Dorothee Ambrosius, Head of CMC Strategy Biologicals, Boehringer Ingelheim, Biberach, Germany
Expertise: Bioprocess development (drug substance and drug product), NBEs and biosimilars development, CMC and comparability concepts, QbD tools

Swapnil Ballal, Senior Director Quality Assurance, Biologics, Dr. Reddy’s Laboratories, Hyderabad, India
Expertise: GMP manufacturing, process development, analytics, process validation and QA

Arindam Bose, Independent Biotechnology & Bioprocessing Consultant, AbiologicsB, LLC, Stonington, USA
Expertise: Bioprocess development, biosimilars, manufacturing strategy, external sourcing, corporate biotech strategy

Jan M Bult, President & CEO, Plasma Protein Therapeutics Association, Annapolis, USA
Expertise: Global industry trends, global healthcare priorities, advocacy, identifying technical, legal and regulatory barriers impacting patient access to care

Charles Cooney,Professor of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, USA
Expertise: Integrated bioprocessing, upstream and downstream technologies,  bioprocess simulation

Suzanne Farid, Professor, Co-Director of the Future Targeted Healthcare Manufacturing Hub, University College London, London, UK
Expertise: Decisional tools, bioprocess economics, drug development cost modelling, capacity planning , portfolio management, risk analysis, multi-criteria decision-making, multi-objective simulation & optimisation, multivariate data analysis

Himanshu Gadgil, Director & CSO, Enzene Biosciences, Pune, India
Expertise: Product development and launches - biosimilars in India and Europe

Lakshmikanth Gandikota, Vice President, Innovation Science and Technology, Intas Pharma, Ahmedabad, India
Expertise: Biosimilars and vaccines development and manufacturing, analytical research and development

Aaron Goerke, Director, Head of Manufacturing Sciences and Technology, F. Hoffmann-La Roche Ltd., Singapore
Expertise: Vaccines, biologics, process development, manufacturing, CMOs, health authorities, process capability, process monitoring, quality systems, technology transfers, cell-free protein synthesis, data and knowledge management, data analytics, change management.

Günter Jagschies, Strategic Customer Relations Leader, GE Healthcare, Freiburg, Germany
Expertise: Manufacturing strategy, process integration, process economics, downstream processing, global healthcare priorities

Racho Jordano, President & CEO, JHL Biotech, Wuhan, China
Expertise: Building and starting companies, international product registration

Subhash Kapre, CEO, Inventprise, Seattle, USA
Expertise: Development and manufacturing of human vaccines, new solutions to make biological products safe and stable

Ashok Kumar, President, Center for Research & Development, IPCA, Mumbai, India
Expertise: Innovative research and development of biosimilars

Ineui Lee, Professor, University of Kobe, Kobe, Japan
Expertise: CMC related development, CMC regulatory affairs, process evaluation/validation

Linda Hwee-Lin Lua, Professor & Protein Expression Facility Director, University of Queensland, Brisbane, Australia
Expertise: Protein production technologies, vaccine engineering and bioprocessing, virus-like particle technology

Hanuman Mallubhotla, Research Director, Syngene International, Bangalore, India
Expertise: Downstream processing development for recombinant protein therapeutics, CMC package development (EMA)

Geoffrey Pot, Vice President, Head of Technical Services, Shire, Lessines, Belgium
Expertise: Internal and external manufacturing strategy, plasma, cell culture, quality, scale down models

Hari Pujar, Vice President, Tech Development and Manufacturing, Moderna Therapeutics, Cambridge, USA
Expertise: Vaccine process development and manufacturing, strategic oversight of R&D, manufacturing and commercial activities, process, analytical, formulation development, manufacturing, QC, CMC, development of a new modality for human therapy

Anurag Rathore, Professor, Department of Chemical Engineering, Indian Institute of Technology, New Delhi, India
Expertise: Bioprocessing, bioseparations, scale-up, technology transfer, process validation, QbD, PAT, biosimilars

Pranhitha Reddy, President, Gene to BLA Consulting, LLC, Seattle, USA
Expertise: Drug development, regulatory strategy, cell engineering, cell culture process development

Arne Staby, Senior Principal Scientist, Novo Nordisk, Copenhagen, Denmark
Expertise: Manufacturing strategy, downstream processing, IPR, life-cycle management, mathematical modeling

Nigel Titchener-Hooker, Dean of Engineering and Professor of Biochemical  Engineering, University College London, London, UK
Expertise: Advanced biochemical engineering, downstream processing technology, scale down modelling

Nihal Tugçu, Executive Director, Dowsntream Process Development and Engineering for Biologics, Merck & Co, Kenilworth, USA
Expertise: Purification process development, advanced manufacturing technologies, productivity and COGs optimization, process analytical technologies (PAT), clinical manufacturing

Johnson Varghese, Executive Director, Head of Analytical Development Biologics, Celgene, Summit, USA
Expertise: Analytical research and development, CMC, analytical control strategy development

James Weidner, Executive Director, Process Development, Amgen, Singapore.
Expertise: Process development, manufacturing, engineering and automation in commercial facilities

Rolf Werner, Professor of Industrial Biotechnology, University of Tübingen, Tübingen, Germany
Expertise: Viral clearance validation, viral therapeutics, novel affinity resins and membranes, SU equipment facility design, Mab processes, biosimilars processes and biosimilarity

Jinyou Zhang, Senior VP, Head of Bioprocess Development and Manufacturing, BeiGene, Suzhou, China
Expertise: Bioprocess development, cGMP biomanufacturing, CMC, media/cell culture, CMO management, facility, manufacturing quality

 

 

 

028_research.jpg
© Boehringer Ingelheim

Download a copy of the
Scientific Advisory Committee
details here: BPA SAC List for web

 

To contact the Scientific Advisory Committee please send an email to:

sac@bioprocessingasia.net

Our sponsors